Meropenem Injection IP 1g Seized Worth Rs 5.88 Lakhs For DPCO Violations

Mancherial: Today, Under the supervision of M. SrinivasuIu, AD, Karimnagar I, T.Chandana Drugs Inspector, Mancherial,  seized 118×1 gm vials of Asmero 1gm*(Meropenem Injection IP 1g) B.No: CI22159H, M/d: 09/2022,  E/D:  08/2024, Mfd. by: Curehealth pharmaceuticals Pvt Ltd, Vill. Raipur, P.O. Deothi, Tehsil & Dist. Solan, H.P and  Marketed by: Astam Healthcare Pvt Ltd, Vill. Theda, Teh. Nalagarh, Dist. Solan, H.P for the violation of  Para 13, 14(1) & (2) & 24 of DPCO 2013 r/w 1579(E) dated 31.03.2023.

Prices of 27 formulations were revised vide SO 1579(E) dtd 31.3.2023 with respect to WPI @12.1218%. Ceiling Price of Meropenem Injection IP 1g was originally fixed under NLEM, 2022. Ceiling price of this formulation is revised including WPI : Rs 952.68  for 1g vial on 31.3.2023.

Asmero1gm 1 is found printed with MRP on the label: Rs. 4200/- for 1g vial.

Ceiling price + GST(12%) is worked out to be  Rs 1067 per 1g vial.

As per DCOs, the formulation is printed with Excess : Rs. 3133/- per 1g vial.

Therefore, 1g vial is charged excess of  Rs 3133/- i.e., 293 % Excess MRP.  Total Worth of seized formulation is Rs.5,88,000/-

Related Posts

Unapproved drops for dry eyes pose risks: Govt

NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Govt highlights multi-layer framework to curb misleading advertisements

Govt highlights multi-layer framework to curb misleading advertisements

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Study finds rising resistance to a last-resort antibiotic in Africa

Study finds rising resistance to a last-resort antibiotic in Africa